NATCOPHARM.NSNATCOPHARM.NSNSE
Loading
Earnings before interest, taxes, depreciation, and amortization
3Y CAGR
+28.0%/yr
vs +5.0%/yr prior
5Y CAGR
+27.3%/yr
Consistent
Acceleration
+23.0pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
3.3x
Strong expansion
Streak
1 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $20.28B | -5.4% |
| 2025 | $21.44B | +22.5% |
| 2024 | $17.51B | +81.1% |
| 2023 | $9.67B | +271.9% |
| 2022 | $2.60B | -57.1% |
| 2021 | $6.07B | +4.2% |
| 2020 | $5.82B | -26.7% |
| 2019 | $7.95B | -14.2% |
| 2018 | $9.27B | +35.4% |
| 2017 | $6.84B | - |